AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Endava plc
Video analysis: DAVA
All videosNo video analysis for this stock yet. Request one from our team.
News: DAVA
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer
BOTHELL, Wash., Aug. 12, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that its lead product candidate, lasofoxifene, will be featured in multiple presentations at Dava Oncology's 4th Summit on Breast Cancer taking place from August 18-22, 2026, in Kona, Hawaii.
Endava Partners with Wiz to Deliver Integrated Cloud Security for Enterprise AI Adoption
LONDON--(BUSINESS WIRE)--Endava (NYSE ‘DAVA'), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced a collaboration with Wiz, the leading cloud and AI security platform that is now part of Google Cloud. Building on Endava's status as both a Google Cloud Premier Partner and Google Security Partner, Endava has now joined the Wiz Partner Alliance, a global community of partners united by one goal.
